Training program focused on cancer, DNA repair, and epigenetics.
Official title: Epigenetics, DNA repair and Genomics (EDGe) Training Program in Cancer
Funded at University of Texas Hlth Science Center · NIH-10782813 · Data updated 2026-11-12
This program is designed to help students learn about cancer, focusing on how DNA repair and changes in gene activity can affect cancer development, so they can work together with experienced mentors to find new ways to treat the disease.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Science Center NIH-funded |
| Lab location | 1 site (San Antonio, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $179,264 |
| NIH project number | 1T32CA279363-01A1 |
| Project ID | NIH-10782813 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are pre-doctoral students interested in cancer biology and related fields.
✕Less likely to help
Patients who are not pursuing academic or research careers in cancer biology may not receive direct benefits from this program.
What this research studies
This program aims to train pre-doctoral students in the fields of cancer biology, DNA repair, and epigenetics. It offers interdisciplinary training opportunities by connecting students with experienced faculty mentors and a curriculum that covers essential topics in cancer research. Students will engage in collaborative learning and research that explores the relationship between DNA repair mechanisms and epigenetic changes in cancer development. The program emphasizes the importance of understanding these processes to identify potential therapeutic strategies for cancer treatment.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment strategies for various cancers.
How similar studies have gone: Similar interdisciplinary training programs have shown success in advancing cancer research and education.
Where this research is happening
-
University of Texas Hlth Science Center
San Antonio, United States Active
Researchers
- Principal investigator: Malkova, Anna L — University of Texas Hlth Science Center
- Study coordinator: Malkova, Anna L
Related research
Other NIH-funded projects on the same topics.
-
LRP1 controls NSC movement and stroke recovery
This NIH grant studies how a brain receptor called LRP1 helps neural stem cells move to stroke injuries and support recovery in adults.
-
Rural microvascular factors driving brain aging and dementia
This project will study how blood vessel problems in rural communities contribute to brain aging and dementia, using mobile clinics to reach people who live far from major medical centers.
-
How COVID-19 infection and genes may influence memory and dementia risk
This study looks at how getting COVID-19 and a person’s genes together affect the chance of developing memory problems and Alzheimer’s disease later in life.
-
Gene editing therapies to prevent epileptic seizures
A new gene-editing approach aims to reduce seizures in people with epilepsy by directly modifying a brain gene tied to the condition.
-
Blocking the IL-4/13 pathway in allergic asthma and rhinoconjunctivitis to understand why treatments work differently
A high-quality clinical trial will test a targeted therapy in people with allergic asthma and allergic rhinitis to understand why symptoms and responses vary.
-
Hormonal Influences on Inflammation in Endometriosis
A study in adult women with endometriosis looks at how hormones and immune pathways interact to influence inflammation and symptoms.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.